BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 23725476)

  • 1. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
    Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J
    Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
    Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
    Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.
    Hung CS; Liu HH; Liu JJ; Yeh CT; Chang TC; Wu CH; Ho YS; Wei PL; Chang YJ
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S360-8. PubMed ID: 22868917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
    Wang Y; Lu Z; Li Y; Ji D; Zhang P; Liu Q; Yao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1076-9. PubMed ID: 25270212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin suppresses the migratory ability of hepatocellular carcinoma cells.
    Wei PL; Tu CC; Chen CH; Ho YS; Wu CT; Su HY; Chen WY; Liu JJ; Chang YJ
    J Agric Food Chem; 2013 Aug; 61(34):8191-7. PubMed ID: 23899086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
    Fan Q; He M; Deng X; Wu WK; Zhao L; Tang J; Wen G; Sun X; Liu Y
    Cell Biochem Funct; 2013 Jun; 31(4):319-24. PubMed ID: 23001723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
    Yunqiao L; Vanke H; Jun X; Tangmeng G
    Hepatogastroenterology; 2014; 61(133):1302-7. PubMed ID: 25436301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.
    Shen G; Lin Y; Yang X; Zhang J; Xu Z; Jia H
    BMC Cancer; 2014 Jun; 14():393. PubMed ID: 24890815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
    Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
    Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
    Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma.
    Zhang XL; Huang CX; Zhang J; Inoue A; Zeng SE; Xiao SJ
    Oncol Rep; 2013 Aug; 30(2):809-14. PubMed ID: 23756565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.